Literature DB >> 10860507

Quantitative measurement of sphingosine 1-phosphate by radioreceptor-binding assay.

N Murata1, K Sato, J Kon, H Tomura, F Okajima.   

Abstract

In Chinese hamster ovary cells overexpressing Edg-1, one of the sphingosine 1-phosphate (S1P) receptor subtypes, [(3)H]S1P binding was displaced by unlabeled S1P with IC(50), a half-maximal concentration to inhibit the binding, of about 20 nM. This radioreceptor binding was used for quantitative measurement of S1P. Among the various lipids employed, only sphingosylphosphorylcholine (SPC), other than S1P, practically displaced the binding; however, the potency of SPC was about 100 to 1000 times less than that of S1P. Thus, SPC bound to the S1P receptors inefficiently. Furthermore, before the application of test samples to this assay, S1P was partially purified: the lipid was extracted first into the aqueous phase and separated from other lipids under alkaline conditions, and then reextracted into the chloroform phase under acidic conditions. With this assay, we could specifically and quantitatively measure S1P from 2 to 40 pmol per assay well in biological samples including serum samples and various tissues. This assay also allowed us to measure the change in cellular S1P content in U937 cells after treatment with exogenous sphingosine. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10860507     DOI: 10.1006/abio.2000.4580

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  28 in total

Review 1.  Sphingosine-1-phosphate antibodies as potential agents in the treatment of cancer and age-related macular degeneration.

Authors:  Roger A Sabbadini
Journal:  Br J Pharmacol       Date:  2011-03       Impact factor: 8.739

Review 2.  Insights into the pharmacological relevance of lysophospholipid receptors.

Authors:  Tetsuji Mutoh; Richard Rivera; Jerold Chun
Journal:  Br J Pharmacol       Date:  2012-02       Impact factor: 8.739

3.  Sphingosine-1-phosphate and calcium signaling in cerebellar astrocytes and differentiated granule cells.

Authors:  Paola Giussani; Anita Ferraretto; Claudia Gravaghi; Rosaria Bassi; Guido Tettamanti; Laura Riboni; Paola Viani
Journal:  Neurochem Res       Date:  2006-12-07       Impact factor: 3.996

Review 4.  Sphingosine-1-phosphate receptors: biology and therapeutic potential in kidney disease.

Authors:  S-K Jo; A Bajwa; A S Awad; K R Lynch; M D Okusa
Journal:  Kidney Int       Date:  2008-03-05       Impact factor: 10.612

5.  Fluid shear stress modulates endothelial cell invasion into three-dimensional collagen matrices.

Authors:  Hojin Kang; Kayla J Bayless; Roland Kaunas
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-09-19       Impact factor: 4.733

Review 6.  Sphingolipids in inflammation: pathological implications and potential therapeutic targets.

Authors:  Graeme F Nixon
Journal:  Br J Pharmacol       Date:  2009-06-25       Impact factor: 8.739

7.  Characterization and direct quantitation of sphingoid base-1-phosphates from lipid extracts: a shotgun lipidomics approach.

Authors:  Xuntian Jiang; Xianlin Han
Journal:  J Lipid Res       Date:  2006-05-08       Impact factor: 5.922

8.  Assessment of the role of sphingosine 1-phosphate and its receptors in high-density lipoprotein-induced stimulation of astroglial cell function.

Authors:  Enkhzol Malchinkhuu; Koichi Sato; Takeshi Muraki; Koichi Ishikawa; Atsushi Kuwabara; Fumikazu Okajima
Journal:  Biochem J       Date:  2003-03-15       Impact factor: 3.857

9.  Elevated adenosine signaling via adenosine A2B receptor induces normal and sickle erythrocyte sphingosine kinase 1 activity.

Authors:  Kaiqi Sun; Yujin Zhang; Mikhail V Bogdanov; Hongyu Wu; Anren Song; Jessica Li; William Dowhan; Modupe Idowu; Harinder S Juneja; Jose G Molina; Michael R Blackburn; Rodney E Kellems; Yang Xia
Journal:  Blood       Date:  2015-01-13       Impact factor: 22.113

10.  Interaction of sphingosine 1-phosphate with plasma components, including lipoproteins, regulates the lipid receptor-mediated actions.

Authors:  N Murata; K Sato; J Kon; H Tomura; M Yanagita; A Kuwabara; M Ui; F Okajima
Journal:  Biochem J       Date:  2000-12-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.